Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01817387 · ClinicalTrials.gov registry record · NA
Enhancing Motivation in Recent Onset Schizophrenia
A NA study, sponsored by University of California, San Francisco.
- Terminated
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT01817387 is a NA study that was terminated before completion, run by University of California, San Francisco. The registered enrollment target is 20 participants.
The verdict
NCT01817387, a NA study, was terminated before completion, sponsored by University of California, San Francisco.
- TERMINATED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
This project will result in the development of a personalized intervention strategy to improve motivation for treatment engagement and functional outcomes in individuals with a recent onset of schizophrenia. Motivational impairment is arguably the single most important factor that determines a patient's ability to engage in and adhere to effective treatment. In our study, sixty participants will be enrolled in a randomized controlled trial comparing the feasibility and tolerability of two types of motivational interventions (Daily Goals or PRIME), and a neuroplasticity-based cognitive training program. Participants are randomized to either receive Daily Goals or PRIME for 8 weeks, after which, both conditions will also receive an 8-week course of cognitive training delivered via iPads. Participants will undergo pre/post-testing and a 6-month follow-up to determine feasibility and efficacy of the interventions. By enhancing motivation, schizophrenia patients would be able to engage more fully with treatment and develop full and productive lives. This study may also pave the way forward for other health conditions in which motivational impairments impede health outcomes. All assessments will be conducted at the University of California, San Francisco; however, we offer some assessments to be done remotely.
Interventions
- BEHAVIORAL Cognitive Training
- BEHAVIORAL PRIME
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2014-07 |
| Est. Completion | 2018-03-20 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01817387
The ClinicalTrials.gov registry entry for NCT01817387 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Cognitive Training is the first listed.
NCT01817387 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01817387 about?
NCT01817387 is a clinical study titled "Enhancing Motivation in Recent Onset Schizophrenia". This project will result in the development of a personalized intervention strategy to improve motivation for treatment engagement and functional outcomes in individuals with a recent onset of schizophrenia. Motivational impairment is arguably the single most important factor that determines a patie...
What is the current status of trial NCT01817387?
This trial is currently terminated. It is a NA study. The enrollment target is 20 participants. The study started on 2014-07. Estimated completion is 2018-03-20.
What interventions are being tested in trial NCT01817387?
The interventions under investigation include: Cognitive Training (BEHAVIORAL), PRIME (BEHAVIORAL).
Who is sponsoring clinical trial NCT01817387?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.